7 studies found for:    rFVIIIFc
Show Display Options
Rank Status Study
1 Enrolling by invitation Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A
Condition: Hemophilia A
Intervention: Drug: BIIB031 (rFVIIIFc)
2 Completed Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: rFVIIIFc
3 Completed
Has Results
Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A
Condition: Severe Hemophilia A
Interventions: Drug: Factor VIII (rFVIIIFc);   Drug: Advate®
4 Recruiting An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: rFVIIIFc
5 Completed
Has Results
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
Condition: Hemophilia A
Interventions: Drug: BIIB031 (rFVIIIFc);   Drug: FVIII (PK subgroup only)
6 Not yet recruiting Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes
Conditions: Hemophilia A;   Hemophilia B
Interventions: Biological: rFVIIIFc;   Biological: rFIXFc;   Drug: non-Fc FVIII replacement products;   Drug: non-Fc FIX replacement products
7 Active, not recruiting Pharmacokinetics of BIIB031 at 2 Vial Strengths
Condition: Severe Hemophilia A
Intervention: Biological: BIIB031 (rFVIIIFc)

Indicates status has not been verified in more than two years